Table 1 Baseline characteristics of participants categorized by enrollment site of the Swedish CArdioPulmonary bioImage study (SCAPIS) cohort.

From: The association between novel urinary kidney damage biomarkers and coronary atherosclerosis in an apparently healthy population

 

Enrollment site

Malmö (N = 4,911)

Uppsala (N = 4,717)

N

Age, years*

57.4 (4.3)

57.7 (4.4)

9,628

Female, n (%)

2,619 (53.3%)

2,422 (51.3%)

9,628

Country of birth, n (%)

  

9,590

Scandinavia

3,849 (78.7%)

4,233 (90.0%)

 

Europe

670 (13.7%)

183 (3.9%)

 

Asia

257 (5.3%)

189 (4.0%)

 

Other area

112 (2.3%)

97 (2.1%)

 

Smoking status, n(%)

  

9,628

Never smoker

2,089 (42.5%)

2,612 (55.4%)

 

Former smoker

1,852 (37.7%)

1,445 (30.6%)

 

Current smoker

846 (17.2%)

421 (8.9%)

 

Diabetes Mellitus, n(%)

242 (5.1%)

197 (4.4%)

9,179

Body mass index*

27.3 (4.58)

27.0 (4.35)

9,628

Systolic blood pressure (mmHg)*

122 (16)

125 (16)

9,619

Diastolic blood pressure (mmHg)*

75 (10)

77 (10)

9,617

Plasma Glucose level (mg/dl)*

101 (23.3)

103 (18.2)

9,624

Albumin creatinine ratio (ug/mg)

8.62 [3.32;21.2]

2.91 [1.12;10.7]

9,424

KIM-1/Cr (ng/mg)

-

0.71 [0.33;1.28]

4,652

Osteopontin/Cr (pg/mg)

828,852 [529,830;1172,904]

817,184 [526,880;1180,364]

9,541

DKK-3/Cr (pg/mg)

415 [225;789]

475 [264;908]

9,541

EGF/Cr (pg/mg)

-

20,290 [15,280;27,748]

4,654

Anti-hyperlipidemia treatment, n (%)

403 (8.6%)

348 (7.8%)

9,171

Anti-diabetes treatment, n (%)

206 (4.4%)

159 (3.6%)

9,169

CCTA:

  

9,187

Group 1 (no stenosis)

2,780 (58.2%)

2,638 (59.8%)

 

Group 2 (< 50% stenosis)

1,653 (34.6%)

1,433 (32.5%)

 

Group 3 ( > = 50% stenosis)

341 (7.1%)

342 (7.8%)

 

Coronary artery calcium score (CACS) group, n (%)

  

9,272

Group 1 (= 0)

2,666 (56.1%)

2,806 (62.1%)

 

Group 2 (0.1–100)

1,424 (30.0%)

1,216 (26.9%)

 

Group 3 (101–400)

437 (9.2%)

337 (7.5%)

 

Group 4 (> 401)

225 (4.7%)

161 (3.6%)

 
  1. CCTA: coronary computed tomography angiography.
  2. CCTA group: 1: no stenosis/2: <50% stenosis or calcium blooming/3: >=50% stenosis or stent or CABG.
  3. CACS group: Group 1 (CACS < 10)/ Group 2 (11–100)/ Group 3 (101–400)/ Group 4 (> 401).
  4. Continuous variables are presented as *mean (standard deviation) or median [interquartile range] as appropriate. The median was presented for Albumin creatinine ratio, KIM-1/Cr, Osteopontin/Cr, DKK-3/Cr, and EGF/Cr.